Cristina Jiménez - Concepedia

Author

Cristina Jiménez

Instituto de Investigación Biomédica de Salamanca ORCID

Also Known As

C Jimenez, C Jiménez, C. Jimenez, C. Jiménez, Carmen Mochón Jiménez, Cristina Jimenez, Cristina Jiménez, Cristina Jiménez, Cristina Nieto Jiménez, Dietrich Herrmann

136

Publications

Citations

H-Index

Concepts

All Affiliations

Instituto de Investigación Biomédica de Salamanca Centro de Investigación del Cáncer Universidad de Salamanca Centro de Investigación Biomédica en Red de Cáncer Clinica Universidad de Navarra

About

Cristina Jiménez is an author at Instituto de Investigación Biomédica de Salamanca specializing in medicine, pathology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	759
2	Health Sciences	3	3	228
3	Engineering	1	1	50
4	Natural Sciences	1	1	33
5	Social Sciences	1	1	72

Cristina Jiménez

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma Juan Flores‐Montero, Luzalba Sanoja-Flores, Bruno Paiva, Leukemia	2017	626
Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma Joaquín Martínez‐López, Juan José Lahuerta, François Pépin, Blood	2014	424
MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenström’s macroglobulinemia Cristina Jiménez, Elena Sebastián, Carmen Chillón, Leukemia Myd88 L265pDisease MechanismGenetic DisorderPathogenesisPathology	2013	264
C1013G/CXCR4 acts as a driver mutation of tumor progression and modulator of drug resistance in lymphoplasmacytic lymphoma Aldo M. Roccaro, Antonio Sacco, Cristina Jiménez, Blood	2014	200
Detailed characterization of multiple myeloma circulating tumor cells shows unique phenotypic, cytogenetic, functional, and circadian distribution profile Bruno Paiva, Teresa Paíno, José-María Sayagués, Blood	2013	170
Critical evaluation of ASO RQ-PCR for minimal residual disease evaluation in multiple myeloma. A comparative analysis with flow cytometry Noemí Puig, María Eugenia Sarasquete, Ana Balanzategui, Leukemia Hematological MalignancyOncologyMedicineAso Rq-pcrHematology	2013	168
Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma Alejandro Medina, Noemí Puig, Juan Flores‐Montero, Blood Cancer Journal	2020	109
The cellular origin and malignant transformation of Waldenström macroglobulinemia Bruno Paiva, Luís A. Corchete, María‐Belén Vídriales, Blood	2015	97
Insights into the genomic landscape of MYD88 wild-type Waldenström macroglobulinemia Zachary R. Hunter, Lian Xu, Nickolas Tsakmaklis, Blood Advances	2018	89
Highly sensitive <i>MYD88</i> <sup>L265P</sup> mutation detection by droplet digital polymerase chain reaction in Waldenström macroglobulinemia Daniela Drandi, Elisa Genuardi, Irene Dogliotti, Haematologica	2018	81

Page 1